Filing Details
- Accession Number:
- 0001127602-23-014739
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-05 16:54:07
- Reporting Period:
- 2023-05-03
- Accepted Time:
- 2023-05-05 16:54:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310158 | Merck & Co. Inc. | MRK | Pharmaceutical Preparations (2834) | 221918501 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601572 | A Rita Karachun | Merck &Amp; Co., Inc. 126 East Lincoln Avenue Rahway NJ 07065 | Sr. Vp Fince-Global Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-05-03 | 803 | $117.89 | 45,363 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-03 | 276 | $117.89 | 45,087 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2023-05-04 | 949 | $118.22 | 46,036 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-04 | 326 | $118.22 | 45,710 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2023-05-04 | 15,875 | $62.07 | 61,585 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-04 | 15,875 | $117.53 | 45,710 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2023-05-03 | 803 | $0.00 | 803 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2023-05-04 | 949 | $0.00 | 949 | $0.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-05-04 | 15,875 | $0.00 | 15,875 | $62.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,608 | 2023-05-03 | 2025-05-03 | No | 4 | M | Direct |
| 951 | 2022-05-04 | 2024-05-04 | No | 4 | M | Direct |
| 0 | 2018-05-05 | 2027-05-04 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.5000 to $117.6200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
- Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
- These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
- The option became exercisable in equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.
Billionaire Hedge Funds
